The research appears in the October issue of The Journal of the American Dental Association. It looks at viruses in the mouth and their links to the gut, brain, immune system and microbiome.
The review, titled "Oral Virome in Health and Disease," examines the oral-gut-brain axis. It also sets out how little researchers know about the estimated 380 trillion viruses living in the human body.
A SAM.gov notice published on October 1, 2026, concerned NIH procurement and administrative activity and warned that data updates could be delayed around the end of the financial year. It did not confirm the UCLA project's funding, launch or research results.
UCLA takes a leading role in virome research
The UCLA School of Dentistry received a reported $20.6 million grant from the National Institutes of Health. The money would establish one of five nationwide Human Virome Characterization Centers.
If confirmed, it would be the largest NIH grant ever awarded to the dental school. UCLA would also be the only centre in the programme headquartered at a dental school. No separate NIH announcement in the available results confirms the amount, UCLA's status as one of five centres or the date on which the funding was disbursed.
The details remain unconfirmed.
The size of the reported award sits beside the practical training focus described in an earlier dental access report. The two developments have different aims. Together, they show how dental schools are being asked to shape the future workforce and the evidence base for oral healthcare.
NIH eRA Commons generally provides a project title, principal investigator and award amount after a grant is awarded. The relevant public card was not available without authorization in the reviewed result, so those parameters could not be checked independently.
What the oral virome could reveal
A reliable baseline could help researchers spot virome changes linked to disease. It could also support work on disease prediction, prevention and precision health.
The proposed research covers periodontal disease, dental caries, inflammation and immune function. It also examines the link between oral health and health across the body.
Timing matters.
If oral viruses produce measurable signals before symptoms appear, saliva and other oral samples could one day help identify the risk of oral and systemic disease earlier. The article presents that as a possible future direction, not an established diagnostic method.
The available search results showed no later clinical results, regulatory decisions or official government confirmation of an oral-virome early-warning test.
Patients' oral microbiome and virome profiles could also shape prevention and treatment. Dr. Hernandez-Kapila said the work could support the oral delivery of therapeutics such as antiviral agents or vaccines.
She also said it could shift the oral cavity from a place focused mainly on detection and treatment into a window on overall human health. The programme is still dealing with basic questions about how to characterise the oral virome and define health across different populations and stages of life.
It is not a finished clinical service.
JADA Editor-in-Chief Tim Wright, D.D.S., said viruses are the most abundant and diverse biological entities on Earth. Trillions live in the body without causing disease, while interacting with cells and influencing the microbiome, health and development.
The article is part of JADA's Oral Science Trends series. The series presents invited reviews on biomedical and clinical developments relevant to dental care.
The October issue also covers smart peptide-based materials, opioid prescribing for tooth extractions and toothpaste-induced contact stomatitis. The virome feature has the biggest long-term implications for dentistry because it places oral samples and dental research within a wider precision-health framework.
Its immediate contribution is not a new treatment. It sets a clearer research agenda and could help dentistry study disease before it becomes clinically visible.
For transparency, the available SAM.gov notice concerns NIH administrative and procurement activity, not UCLA's research findings or grant parameters. The notice also says public data updates may be delayed around the close of the financial year.
It is not evidence that the centre has produced clinical results.
